Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effekten av helseopplæring på kunnskap, holdning og praksis ved posteksponeringsprofylakse

1. november 2026 oppdatert av: Fatma Ali Mahmoud Hussein, Aswan University

Betydningen av helseopplæring for kunnskap, holdning og praksis ved posteksponeringsprofilakse blant helsearbeidere ved Aswan University Hospital, Egypt

The goal of this study is to learn whether a short education programme helps healthcare workers know more about post-exposure prophylaxis (PEP). PEP is medicine taken soon after contact with blood or body fluids, to lower the chance of infection. The study takes place at Aswan University Hospital in Egypt.

The main questions it aims to answer are:

Do healthcare workers know more about PEP three months after the programme than before it?

Do their attitudes toward PEP change?

Do their reported actions change, such as hepatitis B vaccination, use of PEP after an exposure, and finishing the prescribed course?

Participants are doctors, nurses, and laboratory and blood bank staff who work with patients or blood samples. They will:

Fill out a questionnaire before the programme.

Attend four 2-hour teaching sessions over two weeks.

Fill out the same questionnaire about three months later.

All participants receive the programme. There is no comparison group. Researchers will compare each person's answers before and after the programme to see what changed.

Studieoversikt

Detaljert beskrivelse

Design. This is a single-group, before-and-after (quasi-experimental) study. Each participant completes a baseline questionnaire before teaching and a follow-up questionnaire about three months after their group finishes teaching. Coded identifiers link the two questionnaires. The study ran from 30 January 2026 to 30 June 2026.

Setting and participants. The study took place at Aswan University Hospital in southern Upper Egypt. Staff were selected by stratified random sampling from three groups: physicians and clinically active academic staff, nurses, and laboratory and blood bank staff. Workers had to be actively employed in one of these groups, have worked at the hospital for at least six months, and give written informed consent. Non-clinical, housekeeping and auxiliary staff were excluded. In total, 380 workers were selected, and the target was 340 with complete before-and-after data.

Intervention. The programme had four 2-hour sessions over two weeks. Topics were:

Recognising and reporting an exposure.

First aid.

Assessing the source patient and the exposure.

Access to PEP in the hospital.

Hepatitis B vaccination.

HIV PEP timing and duration.

Adherence, counselling and follow-up testing.

The programme also covered the difference between HIV prophylaxis, hepatitis B prevention and hepatitis C follow-up. Teaching used slides, short videos, case scenarios, group discussion and printed materials. Physicians were taught in English, and nurses and laboratory staff in Arabic.

Measures. A questionnaire, adapted from published PEP surveys and available in Arabic and English, was used at both time points.

Primary outcome: change in a five-item knowledge score (0-5), calculated as follow-up score minus baseline score.

Secondary outcomes: change in a seven-item attitude and belief score (0-7), and individual practice indicators. These are self-reported hepatitis B vaccination, PEP use after exposure, time to starting PEP, and completion of the prescribed course.

Analysis. Paired changes are tested with the Wilcoxon signed-rank test for scores and the exact McNemar test for yes/no responses. Confidence intervals are reported for paired differences. The sample size was calculated to estimate a proportion with 5% precision, not to detect a difference between paired groups.

Changes from the original registration. The original record described nine knowledge questions and threshold-based classifications of knowledge, attitude and practice. The final analysis uses a five-item knowledge score, a seven-item attitude total without an overall classification, and individual practice indicators. The dates were updated to the actual start (30 January 2026) and completion (30 June 2026).

Studietype

Intervensjonell

Registrering (Faktiske)

340

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Aswān, Egypt
        • Aswan faculty of Medicine

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

19 år til 55 år (Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. HCWs at the selected departments (physicians, nurses and housekeepers).
  2. Age >18 years old and below 60 years old in both Genders.
  3. HCWs which have direct contact with blood and body fluids.

Exclusion Criteria:

  1. Age<18 years old and above 60 years old.
  2. Non-medical staff at Aswan university hospital.
  3. Health care workers which have no contact with blood or body fluids.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Health Care workers

About 340 participants of heath care workers undergoing assessment of knowledge, attitude and practice about post-exposure prophylaxis among health care workers at Aswan university hospital, Egypt Then they will undergo lecturers about about post-exposure prophylaxis, then reassessment will be done after 3 months

  1. Assess the baseline knowledge, attitudes and practices of health care workers at Aswan university hospital towards postexposure prophylaxis against blood-borne viral infection.
  2. Provide an intense post exposure prophylaxis health education sessions.
  3. Evaluate changes in post exposure prophylaxis knowledge, attitudes and practices after the health education intervention.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Health Practice Change
Tidsramme: 3 Months

Assessment of participants after taking health education lecturers about post-exposure prophylaxis regrading to knowledge, attitude and practice and this done by questionnaire as :The questionnaire consisted of three sections assessing knowledge, attitude, and practice regarding post-exposure prophylaxis (PEP).

Section B assessed knowledge using nine close-ended questions, with adequate knowledge defined as ≥75% correct answers.

Section C included seven items evaluating attitudes toward the importance and effectiveness of PEP, with scores ≥75% indicating a good attitude.

Section D assessed PEP practices through nine questions, and good practice was defined as positive responses to more than 75% of items.

3 Months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studiestol: Shaimaa Sayed Abdelrheem, M.D, Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

30. januar 2026

Primær fullføring (Faktiske)

30. juni 2026

Studiet fullført (Faktiske)

30. juni 2026

Datoer for studieregistrering

Først innsendt

11. desember 2025

Først innsendt som oppfylte QC-kriteriene

4. januar 2026

Først lagt ut (Faktiske)

9. januar 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

4. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere